WHO ICTRP trial
Intralesional MMR (Measles,mumps and rubella) vs intralesional BCG (Bacillus…
CTRI/2025/11/097031 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/11/097031 |
|---|---|
| Public title | Intralesional MMR (Measles,mumps and rubella) vs intralesional BCG (Bacillus calmette-guerin) in the treatment of Verucca vulgaris |
| Scientific title | Intralesional MMR (Measles,mumps and rubella) vs intralesional BCG (Bacillus calmette -guerin)in the treatment of Verucca vulgaris: A Randomized controlled study - NIL |
| Primary sponsor | Jawaharlal Nehru Institute Of Medical Sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: B078- Other viral warts |
| Interventions | Intervention1: Intralesional BCG(Bacillus calmette-guerin)-Group B: Freeze-dried BCG will be reconstituted with 1ml of normal saline (diluent) using sterile syringe and sterile needle . All the eligible patients will be given 0.1ml BCG… |
| Registration date | Jul 11, 2025 |
| Target size | 62 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: